/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg?resize=400%2C240&ssl=1 "Wegovy’s heart benefits due to more than weight loss, Novo says")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg?resize=80%2C80&ssl=1 "Wegovy’s heart benefits due to more than weight loss, Novo says")
PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSYGKPNE5ZPRXH2OTG23T4DSYI.jpg?resize=400%2C240&ssl=1 "US FDA authorizes Novavax’s updated COVID shot, shares rise")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSYGKPNE5ZPRXH2OTG23T4DSYI.jpg?resize=80%2C80&ssl=1 "US FDA authorizes Novavax’s updated COVID shot, shares rise")
A vial labelled “Novavax COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Oct 3 (Reuters) – The...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=400%2C240&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=80%2C80&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights...
Sept 15 (Reuters) – The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its vaccine targeting...
Recent Comments